Part of the Auction High-quality laboratory and analysis equipment

Next-generation sequencer Illumina MiSeqDx 410, Iseq 100Auction#A18949-1

Share with

High-quality laboratory and analysis equipment-1
High-quality laboratory and analysis equipment-2
High-quality laboratory and analysis equipment-3
High-quality laboratory and analysis equipment-4
High-quality laboratory and analysis equipment-5
High-quality laboratory and analysis equipment-6
High-quality laboratory and analysis equipment-7
High-quality laboratory and analysis equipment-8
High-quality laboratory and analysis equipment-9
thumbnail-High-quality laboratory and analysis equipment-1
thumbnail-High-quality laboratory and analysis equipment-2
thumbnail-High-quality laboratory and analysis equipment-3
thumbnail-High-quality laboratory and analysis equipment-4
thumbnail-High-quality laboratory and analysis equipment-5
thumbnail-High-quality laboratory and analysis equipment-6
thumbnail-High-quality laboratory and analysis equipment-7
thumbnail-High-quality laboratory and analysis equipment-8
thumbnail-High-quality laboratory and analysis equipment-9

Details

Product Type

Illumina

Type

MiSeqDx 410, Iseq 100

Construction Year

2021

Description

The Illumina MiSeq Dx is a compact, IVD-certified desktop sequencer for clinical applications that uses sequencing-by-synthesis and is designed for small to medium-sized data sets. It is suitable for targeted panels, amplicon sequencing and microbiome analysis in a clinical context, offers validated diagnostic workflows and fulfills regulatory requirements (e.g. EU-IVDR, FDA).

Location

  • 5101 Bergheim, Handelsyentrum 16 (Austria)

Dates

Inspection

Viewing is possible at any time.
Please register in advance by e-mail to: a.weinberger@consense.at

Contact Person

Parts of this page have been machine translated. The German original text applies.

1 / 344 Positions in this Auction

Your individual consultation

Our experts will be happy to advise you. Call +49 40 355059-132 or write to service@netbid.com

Interesting, current, and useful insights from the NetBid magazine

Discover more articles